Who Paid My Doc
Strattice Reconstructive Tissue Matrix BPS
Device Trauma Emergency, Injury, Surgery
PDI M32803140060
General payments
$4,498,196
Research payments
$214,275
Through program year 2025, $4,498,196 in general payments and $214,275 in research payments were reported against Strattice Reconstructive Tissue Matrix BPS (Trauma Emergency, Injury, Surgery).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $373,125 | 1,468 |
| 2025 | Research | $13,186 | 1 |
| 2024 | General | $1,423,657 | 4,021 |
| 2024 | Research | $17,526 | 1 |
| 2023 | General | $1,395,554 | 4,147 |
| 2022 | General | $751,392 | 2,766 |
| 2022 | Research | $60,090 | 2 |
| 2021 | General | $554,467 | 2,509 |
| 2021 | Research | $123,473 | 5 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 33 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 39 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
14,911 general · 9 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.